Joseph Berger

Q: What Schools Are Affiliated With Joseph Berger

Joseph Berger is affiliated with the following schools: University of Kentucky, Federal University of Rio de Janeiro, Stanford University, Columbia University, University of Pennsylvania, Harvard University

Joseph Berger 's AcademicInfluence.com Rankings

Joseph Berger

Medical

#1682

World Rank

#2048

Historical Rank

Neurology

#158

World Rank

#225

Historical Rank

medical Degrees

Joseph Berger

Philosophy

#6113

World Rank

#9087

Historical Rank

Logic

#3302

World Rank

#4435

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

Joseph Berger 's Degrees

Doctorate Medicine Harvard University
PhD Neuroscience Stanford University

Why Is Joseph Berger Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Joseph R. Berger is an American internist and neurologist who is known for his research interests in progressive multifocal leukoencephalopathy , the neurological complications of HIV/AIDS, multiple sclerosis, and other inflammatory disorders of the brain. Particularly, he contributed research on why PML occurs more frequently in AIDS than in other immunosuppressive conditions.

(See a Problem?)

Joseph Berger 's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain (1992) (539)
Early penetration of the blood‐brain‐barrier by HIV (1988) (455)
PML diagnostic criteria (2013) (364)
HIV‐1 infection of subcortical astrocytes in the pediatric central nervous system (1994) (346)
Progressive multifocal leukoencephalopathy in patients with HIV infection. (1998) (316)
Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. (1993) (309)
Progressive multifocal leukoencephalopathy and natalizumab--unforeseen consequences. (2005) (264)
Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal leukoencephalopathy (1992) (253)
Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. (1995) (253)
HIV dementia: the role of the basal ganglia and dopaminergic systems (2000) (209)
Predictive factors for prolonged survival in acquired immunodeficiency syndrome—associated progressive multifocal leukoencephalopathy (1998) (192)
Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group (2018) (182)
Neurosyphilis in HIV-positive and HIV-negative patients: neuroimaging findings. (1995) (170)
Classifying PML risk with disease modifying therapies. (2017) (169)
COVID-19 and the nervous system (2020) (162)
Microangiopathy of the brain, retina, and cochlea (Susac syndrome). A report of five cases and a review of the literature. (1998) (159)
Determinants of survival in progressive multifocal leukoencephalopathy (2009) (158)
Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study (2007) (153)
Oxandrolone in AIDS‐wasting myopathy (1996) (150)
CT, MR, and pathology in HIV encephalitis and meningitis. (1988) (146)
Cerebrospinal fluid dopamine in HIV‐1 infection (1994) (144)
HIV dementia and the basal ganglia. (1997) (136)
MRI findings in Susac’s syndrome (2003) (133)
High Prevalence of Multiple Human Herpesviruses in Saliva from Human Immunodeficiency Virus-Infected Persons in the Era of Highly Active Antiretroviral Therapy (2006) (131)
Neurosyphilis. A comparative study of the effects of infection with human immunodeficiency virus. (1993) (129)
Prolonged survival and partial recovery in AIDS‐associated progressive multifocal leukoencephalopathy (1988) (127)
Neurologic Disease as the Presenting Manifestation of Acquired Immunodeficiency Syndrome (1987) (121)
Cerebrovascular disease in AIDS: a case‐control study (1990) (121)
Acceleration of HIV dementia with methamphetamine and cocaine (2011) (120)
Role of CD4+ and CD8+ T-Cell Responses against JC Virus in the Outcome of Patients with Progressive Multifocal Leukoencephalopathy (PML) and PML with Immune Reconstitution Inflammatory Syndrome (2011) (119)
Neurological complications of herpes simplex virus type 2 infection. (2008) (117)
Progressive multifocal leukoencephalopathy after fingolimod treatment (2018) (111)
Multiple sclerosis‐like illness occurring with human immunodeficiency virus infection (1989) (111)
Neurosyphilis in acquired immunodeficiency syndrome. (1989) (106)
Persistence and pathogenesis of the neurotropic polyomavirus JC (2015) (105)
A double‐blind study comparing carbamazepine with phenytoin as initial seizure therapy in adults (1983) (105)
The neurologic complications of human immunodeficiency virus infection. (1993) (103)
Monoclonal antibodies and progressive multifocal leukoencephalopathy (2009) (102)
Motor neuron disease: A paraneoplastic process associated with anti‐Hu antibody and small‐cell lung carcinoma (1996) (102)
Human immunodeficiency virus type 1 infection of the brain (1993) (100)
Reactivation of JC virus and development of PML in patients with multiple sclerosis (2007) (96)
Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. (2000) (95)
Cytomegalovirus. Induced demyelination associated with acquired immune deficiency syndrome. (1984) (93)
Multifocal fibrosclerosis with hypertrophic intracranial pachymeningitis (1989) (92)
Paroxysmal dystonia as the initial manifestation of multiple sclerosis. (1984) (92)
Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. (1991) (90)
ALS syndrome in patients with HIV-1 infection (2006) (90)
Cerebellar degeneration associated with human immunodeficiency virus infection (1998) (89)
Neuroimaging correlates of HIV-associated BBB compromise (2004) (88)
The neurological complications of bariatric surgery. (2004) (86)
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event (2018) (86)
Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype (2013) (81)
JC virus antibody status underestimates infection rates (2013) (81)
Progressive Multif ocal Leukoencephalopathy and Newer Biological Agents (2010) (81)
The HIV Dementia Scale: Predictive power in mild dementia and HAART (2007) (81)
Acute multifocal placoid pigment epitheliopathy and central nervous system involvement: nine new cases and a review of the literature. (2001) (80)
Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection: a review of the literature with a report of sixteen cases (1988) (78)
Progressive multifocal leukoencephalopathy. (2014) (78)
Progressive multifocal leukoencephalopathy: lessons from AIDS and natalizumab (2006) (77)
Delayed fingolimod-associated asystole (2011) (76)
COVID-19 and MS disease-modifying therapies (2020) (74)
Molecular targets of opiate drug abuse in neuro AIDS (2005) (70)
Progressive multifocal leukoencephalopathy in HIV‐1-infected children (1992) (68)
Tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. (1991) (67)
CNS angiitis in graft vs host disease (2002) (66)
The clinical features of PML (2011) (63)
Tropical spastic paraparesis‐like illness occurring in a patient dually infected with HIV‐1 and HTLV‐II (1991) (62)
The blood brain barrier in HIV infection. (2004) (62)
Treatment-related progressive multifocal leukoencephalopathy: current understanding and future steps (2012) (62)
Fatigue heralding multiple sclerosis (2013) (61)
Active bleeding in hypertensive intracerebral hemorrhage (1982) (61)
Cerebral ischemia and atrial fibrillation (1984) (60)
Neurosyphilis in human immunodeficiency virus type 1-seropositive individuals. A prospective study. (1991) (59)
Frequency and Phenotype of JC Virus-Specific CD8+ T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy (2007) (59)
Relapsing and remitting human immunodeficiency virus—associated leukoencephalomyelopathy (1992) (58)
JC virus detection in bodily fluids: clues to transmission. (2006) (58)
Inflammatory changes and breakdown of microvascular integrity in early human immunodeficiency virus dementia (2011) (58)
Expression of miR-15/107 Family MicroRNAs in Human Tissues and Cultured Rat Brain Cells (2014) (56)
Persistent neurological deficit precipitated by hot bath test in multiple sclerosis. (1983) (56)
Memantine for AIDS Dementia Complex: Open-Label Report of ACTG 301 (2010) (55)
The effect of dimethyl fumarate (Tecfidera™) on lymphocyte counts: A potential contributor to progressive multifocal leukoencephalopathy risk. (2015) (54)
Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: Explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions (2011) (54)
Reassessing the risk of natalizumab-associated PML (2016) (54)
Stroke in HIV infection and AIDS (2009) (54)
A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy (2006) (53)
Association of '(tropical) ataxic neuropathy' with HTLV-II. (1993) (52)
Opportunistic infections and other risks with newer multiple sclerosis therapies (2009) (52)
Asymptomatic and neurologically symptomatic HIV-seropositive subjects: results of long-term MR imaging and clinical follow-up. (1993) (51)
Understanding pathogenesis and treatment of HIV dementia: a role for magnetic resonance? (2002) (50)
Chapter 98 - Neurosyphilis (2014) (50)
Central nervous system opportunistic infections. (1997) (50)
Infection Risk in Patients on Multiple Sclerosis Therapeutics (2015) (50)
Creutzfeldt‐Jakob disease in a physician (1993) (46)
Progressive multifocal leukoencephalopathy and relapsing-remitting multiple sclerosis: a comparative study. (2009) (46)
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies (2017) (46)
The neurologic complications of bariatric surgery. (2014) (44)
The pathogenesis of progressive multifocal leukoencephalopathy. (2011) (44)
Thyroid function in Parkinson disease (1981) (44)
Sorting out the risks in progressive multifocal leukoencephalopathy (2015) (44)
Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin (2012) (42)
Akinetic‐rigid syndrome in a 13‐year‐old girl with HIV‐related progressive multifocal leukoencephalopathy (1993) (41)
Considerations on discontinuing natalizumab for the treatment of multiple sclerosis (2010) (41)
Guillain-Barré syndrome complicating acute hepatitis B. A case with detailed electrophysiological and immunological studies. (1981) (40)
Epidemiological evidence and molecular basis of interactions between HIV and JC virus (2011) (40)
Mass lesions of the brain in AIDS: the dilemmas of distinguishing toxoplasmosis from primary CNS lymphoma. (2003) (40)
Immunosenescence: the Role of Aging in the Predisposition to Neuro-Infectious Complications Arising from the Treatment of Multiple Sclerosis (2017) (39)
Steroids for PML-IRIS (2009) (37)
Cervical myelopathy secondary to violent tics of Tourette’s syndrome (2003) (37)
Re-evaluating the incidence of natalizumab-associated progressive multifocal leukoencephalopathy. (2016) (37)
Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis (2013) (36)
The Neurologic Complications of Scleromyxedema (2001) (35)
Limbic encephalitis associated with thymoma (1990) (35)
Update on Progressive Multifocal Leukoencephalopathy (2012) (35)
Progressive multifocal leukoencephalopathy complicating Wiskott-Aldrich syndrome. Report of a case and review of the literature of progressive multifocal leukoencephalopathy with other inherited immunodeficiency states. (1994) (34)
Progressive multifocal leukoencephalopathy (2007) (34)
Neurological and Ophthalmological Manifestations of Varicella Zoster Virus (2019) (33)
A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy (2015) (32)
Does viral disease underlie ALS? (2001) (32)
Ziconotide Infusion for Severe Chronic Pain: Case Series of Patients with Neuropathic Pain (2006) (32)
Spinal cord syphilis associated with human immunodeficiency virus infection: a treatable myelopathy. (1992) (31)
Sequential cranial MR findings of asymptomatic and neurologically symptomatic HIV+ subjects. (1992) (31)
Clinical spectrum of HTLV-I in south Florida. (1995) (30)
Paraneoplastic Opsoclonus–myoclonus Secondary to Malignant Melanoma (2004) (29)
Functional improvement and symptom management in multiple sclerosis: clinical efficacy of current therapies. (2011) (28)
Reversible Parkinson syndrome complicating postoperative hypoparathyroidism (1981) (28)
Neurosyphilis and the spinal cord: then and now. (2011) (28)
The bone marrow, B cells, and JC virus (2011) (28)
Progressive multifocal leukoencephalopathy and JC Virus-related disease in modern neurology practice. (2014) (27)
HIV encephalitis presenting with severe generalized chorea (1996) (27)
Creutzfeldt-Jakob Disease and eating squirrel brains (1997) (26)
Effect of Anabolic Steroids on HIV-Related Wasting Myopathy (1993) (26)
Reversible parkinsonian syndrome complicating cysticercus midbrain encephalitis (1995) (26)
Brachial amyotrophic diplegia in a patient with human immunodeficiency virus infection: widening the spectrum of motor neuron diseases occurring with the human immunodeficiency virus. (2005) (25)
HIV seropositivity in Guillain‐Barré syndrome (1987) (25)
Persistent Coxsackie B encephalitis: Report of a case and review of the literature (2006) (25)
Central Nervous System Infections With Immunomodulatory Therapies (2015) (24)
Downbeat nystagmus with phenytoin. (1982) (23)
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man (2014) (22)
Cranial neuropathy heralding otherwise occult AIDS-related large cell lymphoma. (1993) (22)
Neurologic consequences of autoimmune polyglandular syndrome type 1 (2008) (22)
Progressive Multifocal Leukoencephalopathy (2015) (21)
Spinal Epidural Abscess (2014) (21)
Thrombolytic therapy for acute stroke in the elderly: an emergent condition in developing countries. (2011) (21)
Chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids following influenza vaccination. (2012) (21)
Encephalitis lethargica (von Economo's encephalitis). (2014) (21)
Hereditary hemorrhagic telangectasia and spinal cord infarct: Case report with a review of the neurological complications of HHT (2008) (21)
Low prevalence of varicella zoster virus and herpes simplex virus type 2 in saliva from human immunodeficiency virus-infected persons in the era of highly active antiretroviral therapy. (2010) (20)
Progressive Multifocal Leukoencephalopathy: Recent Advances and a Neuro-Ophthalmological Review (2015) (20)
Monofocal Acute Inflammatory Demyelination (MAID): A Unique Disorder Simulating Brain Neoplasm (2002) (20)
Headache and human immunodeficiency virus infection: a case control study. (1996) (20)
Cognitive Function in Asymptomatic HIV-1 Infection: The Effects of Age, Education, Ethnicity, and Depression (1992) (20)
Melanoma complicating treatment with natalizumab for multiple sclerosis: A report from the Southern Network on Adverse Reactions (SONAR) (2017) (20)
The basis for modeling progressive multifocal leukoencephalopathy pathogenesis. (2011) (19)
Predictors of severity and functional outcome in natalizumab-associated progressive multifocal leukoencephalopathy (2017) (19)
Familial lipodystrophy associated with neurodegeneration and congenital cataracts (2002) (19)
Vaccines in Multiple Sclerosis (2016) (19)
Benign focal cerebral vasculitis (1995) (18)
Cerebrospinal Fluid 5-Hydroxytryptamine and 5-Hydroxyindoleacetic Acid in HIV-1 Infection (2001) (18)
Intravascular lymphomatosis presenting with sudden hearing loss (2005) (18)
AIDS and stroke risk (2004) (17)
Distribution and Quantity of Sites of John Cunningham Virus Persistence in Immunologically Healthy Patients: Correlation With John Cunningham Virus Antibody and Urine John Cunningham Virus DNA (2017) (17)
Importance and hurdles to drug discovery for neurological disease (2013) (17)
Uncovering the association between fatigue and fatigability in multiple sclerosis using cognitive control. (2019) (17)
Posterior reversible encephalopathy syndrome masquerading as progressive multifocal leukoencephalopathy in rituximab treated neuromyelitis optica. (2014) (17)
Cystinosis of the brain and spinal cord with associated vasculopathy (2009) (17)
Complications of Immunosuppressive/Immunomodulatory Therapy in Neurological Diseases (2012) (16)
Progressive Multifocal Leukoencephalopathy. (2018) (16)
Guillain‐Barré syndrome complicating typhoid fever (1986) (16)
Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy (2016) (16)
Neurological infections: the year of PML and influenza (2010) (15)
Remedies for HIV-associated peripheral neuropathy (2000) (15)
Diagnostic value for culture of cerebrospinal fluid from HIV‐1-infected individuals for opportunistic viruses: a prospective study (1994) (15)
Parinaud syndrome heralding MS (2003) (15)
Neurologists: the last bedside physician-scientists. (2013) (14)
JCV-specific CD4 T cell response: another piece of the puzzle in explaining some aspects of AIDS associated PML. (2003) (13)
The pathogenesis of diffuse infiltrative lymphocytosis syndrome (1998) (13)
Isolated Histoplasma capsulatum Meningoencephalitis in an Immunocompetent Child (2012) (13)
Progressive multi‐focal leucoencephalopathy among ibrutinib‐treated persons with chronic lymphocytic leukaemia (2018) (13)
A brainstem paraneoplastic syndrome associated with prostate cancer (2009) (13)
Progressive multifocal leukoencephalopathy (2000) (13)
The relationship of CPE to HIV dementia (2014) (13)
Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI (2015) (13)
HIV/AIDS and the nervous system (2007) (13)
Infectious myelopathies. (2002) (13)
Manifestations and impact of the COVID‐19 pandemic in neuroinflammatory diseases (2021) (12)
An international screening tool for HIV dementia. (2005) (12)
Progressive multifocal leukoencephalopathy in patients treated with rituximab: a 20-year review from the Southern Network on Adverse Reactions. (2021) (12)
PRIMARY LATERAL SCLEROSIS WITH HIV-1 INFECTION (2008) (12)
A giant MS plaque mimicking PML during natalizumab treatment (2010) (12)
Animal Models for Progressive Multifocal Leukoencephalopathy (2015) (11)
The curious incident of the dog in the nighttime: does the absence of virus replication in Epstein-Barr virus-transformed B cells point to an important feature of JC virus biology? (2010) (11)
Neuro-AIDS in the developing world (2012) (11)
Disease-Modifying Therapy Adherence and Associated Factors in a National Sample of Medicare Patients With Multiple Sclerosis. (2020) (11)
WEST NILE VIRUS MENINGO-ENCEPHALITIS: POSSIBLE SEXUAL TRANSMISSION. (2016) (10)
The Changing Landscape of Progressive Multifocal Leukoencephalopathy (2011) (10)
Varicella vaccination after fingolimod: A case report. (2013) (10)
Is the presence of antibodies in CSF sufficient to make a definitive diagnosis of Lyme disease? (2007) (10)
P234 Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers (2012) (10)
Autoimmune markers in HIV-associated dementia (2003) (10)
Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment (2011) (10)
The hot bath test and multiple sclerosis. (1982) (10)
Vedolizumab does not reduce the CD4+:CD8+ ratio in the CSF of healthy volunteers: P-136. (2011) (9)
Response to Linberg et al. Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients (2008) (9)
The human immunodeficiency virus, type 1: the virus and its role in neurologic disease. (1992) (9)
The “Bedsheet” Babinski (2002) (8)
HIV and the central nervous system (2002) (8)
Substantia nigra depigmentation and exposure to encephalitis lethargica (2012) (8)
Varicella zoster virus rhombencephalomyelitis following radiation therapy for oropharyngeal carcinoma (2016) (8)
Coxsackie B meningoencephalitis in a patient with acquired immunodeficiency syndrome and a multiple sclerosis-like illness (2009) (8)
Chronic inflammatory polyradiculoneuropathy complicated by factor VIII antibody (1983) (8)
THE NEUROLOGICAL COMPLICATIONS OF HIV INFECTION (1988) (8)
Cerebrospinal fluid proteomics and human immunodeficiency virus dementia: Preliminary observations (2005) (8)
CNS fungal infections: A review (2021) (8)
Iatrogenic Fungal Infections of Central Nervous System (2013) (7)
Disease-modifying drugs for multiple sclerosis and JC virus expression (2012) (7)
Updated Incidence of Natalizumab-associated Progressive Multifocal Leukoencephalopathy (PML) and Its Relationship with Natalizumab Exposure Over Time (2815) (2020) (7)
An innovative approach for calculating the work relative value units of clinical activities otherwise concealed. (2011) (7)
Lyme myelopathy: Case report and literature review of a rare but treatable disorder. (2019) (7)
Neurosurgical aspects of human immunodeficiency virus infection. (1992) (7)
History of Syphilis as a Cofactor for the Expression of HIV Infection (1989) (7)
Progressive multifocal leukoencephalopathy. (2007) (7)
1008 No Increase in JC Viremia, Lymphocyte Count, or Circulating CD34+ Hematopoietic Progenitor Cells After Treatment With Vedolizumab, a Humanized Monoclonal Antibody to α4β7 Integrin (2010) (6)
Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer. (2011) (6)
Chronic inflammatory polyradiculoneuropathy associated with alopecia universalis (1998) (6)
Frequency and Phenotype of JC Virus-Specific CD8+ T Lymphocytes in the Peripheral Blood of Patients with Progressive Multifocal Leukoencephalopathy (2007) (6)
Erratum to: Reassessing the risk of natalizumab-associated PML (2016) (6)
The manifold faces of PML and the challenge of diagnosis (2011) (6)
Alien hand syndrome (2006) (6)
Improving risk‐stratification of natalizumab‐associated PML (2021) (6)
Acute transitory cerebellar dysfunction associated with piperazine adipate. (1979) (6)
Guilty by association: Epstein–Barr virus in multiple sclerosis (2022) (6)
Risk Assessment and Minimization for Progressive Multifocal Leukoencephalopathy (PML RAMP): A Program to Assess for Potential Early Signs and Symptoms of PML during Clinical Development of Vedolizumab: 1673 (2013) (6)
Pearls: neurologic complications of HIV/AIDS. (2010) (6)
Genetic testing and HIV dementia: teasing out the molecular mechanisms of disease. (2010) (5)
Treatment and diagnostic accuracy of neurosyphilis at Boston City Hospital's Neurological Unit, 1930–1979 (2012) (5)
Longitudinally extensive transverse myelitis suspected for isolated Neuro-Behçet: A diagnostic conundrum. (2015) (5)
Erratum: Progressive multifocal leukoencephalopathy in a patient with Hodgkin lymphoma treated with brentuximab vedotin (Leukemia and Lymphoma (2012) 53:11 (2283-2286)) (2014) (5)
Misdiagnosis of multiple sclerosis in a female heterozygote with Fabry's disease. (2019) (5)
Clinical instrument to retrospectively capture levels of EDSS. (2019) (5)
A careful neurologic examination should precede neuroimaging studies in HIV-infected patients with headache. (2000) (5)
Impact of cervical stenosis on multiple sclerosis lesion distribution in the spinal cord. (2020) (5)
HIV meningitis and dementia (2003) (5)
Memory and the mammillothalamic tract. (2004) (5)
Neurologic complications of human immunodeficiency virus infection. What diagnostic features to look for. (1987) (5)
Varicella zoster virus (VZV) oculomeningoencephalomyeloradiculitis: a previously undescribed constellation (2019) (5)
PD-1 inhibition: a novel approach to the treatment of progressive multifocal leukoencephalopathy. (2019) (5)
The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine (2012) (4)
Cerebrospinal fluid xanthochromia with rifampin (1982) (4)
Human immunodeficiency virus and bilateral optic atrophy (2000) (4)
CJD in health care workers (1993) (4)
Reply to “‘Thinking without thinking’ about natalizumab and PML” (2008) (4)
421 – Brain Abscess and Parameningeal Infections (2011) (4)
The financial contribution of the multiple sclerosis specialist. (2017) (4)
Clinical Progressive Multifocal Leukoencephalopathy: Diagnosis and Treatment (2002) (4)
The elimination of circulating Epstein-Barr virus infected B cells underlies anti-CD20 monoclonal antibody activity in multiple sclerosis: A hypothesis. (2022) (4)
Deciding on the Best Multiple Sclerosis Therapy: Tough Choices. (2018) (4)
Introduction to HIV infection and neuro-AIDS. (2007) (4)
No association between vedolizumab exposure and serum JC virus levels. (2011) (4)
Memantine for AIDS dementia complex (2010) (4)
Political Correctness of Medical Documentation. (2015) (4)
Incidence of natalizumab-associated progressive multifocal leucoencephalopathy and its relationship with the pattern of natalizumab exposure over time (2019) (4)
Neurological Deficits Following the Hot Bath Test in Multiple Sclerosis-Reply (1985) (3)
Detecting multiple sclerosis mimics early (2012) (3)
Too much of a good thing? (2011) (3)
Neurologic critical care in patients with human immunodeficiency virus 1 infection. (1993) (3)
Myelopathy and coinfection with HIV and HTLV-I (1997) (3)
Moyamoya: Another multiple sclerosis mimic. (2012) (3)
Cryptococcal Meningitis Reported With Fingolimod Treatment Case Series (3)
Neurological manifestations of coronavirus infections (2020) (3)
Exacerbation of HIV-associated myopathy by zidovudine. (1991) (3)
Contralateral Optic Neuritis Following Silicone Oil Endotamponade for Retinal Detachment (2016) (3)
Against all odds: surviving rhino–orbital–cerebral mucormycosis: a case report (2012) (3)
Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event (2018) (3)
Identification of potential antibody markers in HIV-associated dementia (2004) (2)
Other opportunistic infections of the central nervous system in AIDS. (2007) (2)
Gastrointestinal pathologic findings of teriflunomide associated diarrhea (2022) (2)
Molluscum contagiosum in the setting of Fingolimod: The experience at one institution. (2021) (2)
Idiopathic granulomatous angiitis of the CNS manifesting as diffuse white matter disease (1998) (2)
Multiple Sclerosis‑like Illness with HIV Infection (1988) (2)
AIDS and Other Immunocompromised States (1990) (2)
Balint's syndrome in subacute HIV encephalitis. (1993) (2)
Opportunistic infections of the nervous system in AIDS. (2005) (2)
A Programme for Risk Assessment and Minimisation of Progressive Multifocal Leukoencephalopathy Developed for Vedolizumab Clinical Trials (2018) (2)
Resistance exercise and oxandrolone for men with HIV-related weight loss. (2000) (2)
The interface of infectious disease and neuro-ophthalmology. (2012) (2)
Diagnosing neurosyphilis: the value of the cerebrospinal fluid VDRL or lack thereof (1989) (2)
The cerebellar seizures of Hughlings Jackson. (2000) (2)
Isolated central nervous system histoplasmosis in an immunocompetent patient: 53-month hiatus to diagnosis and treatment. (2010) (2)
Management approach including pembrolizumab for fingolimod-associated progressive multifocal leukoencephalopathy in a patient with relapsing-remitting multiple sclerosis (2022) (2)
Neurological and Cognitive Correlates of T4 Lymphocyte Counts in Asymptomatic HIV Seropositive Adults (1989) (2)
A Retrospective Study of Chronic Relapsing Inflammatory Optic Neuropathy (CRION) (P6.293) (2014) (2)
Next-generation sequencing of tissue (2016) (2)
EVALUATION AND MANAGEMENT OF INTRACRANIAL MASS LESIONS IN AIDS : REPORT OFTHE QUALITY STANDARDS SUBCOMMITTEE OF THE AMERICAN ACADEMY OF NEUROLOGY. AU THOR'S REPLY (1998) (2)
Vedolizumab Does Not Reduce the CD4+:CD8+ Ratio in the CSF of Healthy Volunteers: 1221 (2011) (2)
Inhibition of concanavalin A-inducible suppressor cell function in multiple sclerosis by adrenocorticotropic hormone (1982) (1)
Neurological Complications of Ethylene Glycol Intoxication (2016) (1)
Neuropathogenesis of viral infections (2020) (1)
The relationship of syphilis to small vessel stroke in the absence of neurosyphilis: real or imaginary? (2021) (1)
Soluble Immune Mediator Profiles in Cerebrospinal Fluids from HIV‑1 Infected Individuals with Different Neuropathologies (1992) (1)
Active bleeding in hypertensive intracranial hemorrhage (1983) (1)
Progressive Multifocal Leukoencephalopathy (PML) (2003) (1)
Immunophenotyping in Asymptomatic and Neurologically Symptomatic Anti‑HIV‑1 Positive and Anti‑HTLV‑1 Negative Men (1989) (1)
Homonymous hemianopsia complicating treatment of postoperative epistaxis (2006) (1)
Cytokines and Immunoglobulins (Ig) in Cerebrospinal Fluid (CSF) of Anti‑HIV‑1 Positive, Anti‑HTLV‑1 Negative Asymptomatic Men (1989) (1)
Confirmation of concanavalin-A (Con-A)-inducible suppressor cell function in multiple sclerosis (MS) (1982) (1)
Acute central cord syndrome with bodybuilder sign (2007) (1)
Activation of HERV-K and response to antiretroviral therapy in patients with HIV infection and motor neuron disease (I4-1A) (2015) (1)
Amebic infections of the central nervous system (2022) (1)
Bedside predictors of outcome in meningitis (2019) (1)
Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra (2021) (1)
Evaluation and management of intracranial mass lesions in AIDS: Report of the Quality Standards Subcommittee of the American Academy of Neurology (1998) (1)
T4 Lymphocyte Counts and Presence of Abnormalities on Neurological Examination in Asymptomatic HIV Seropositive Subjects (1989) (1)
Lymphocyte Phenotypes in HIV‑1 Associated Neurological Disease (1990) (1)
Author response: Progressive multifocal leukoencephalopathy after fingolimod treatment (2019) (1)
CHAPTER 49 – Thermal Injury of the Nervous System (2009) (1)
Serological and Cerebrospinal Fluid Parameters Related to Syphilis in HIV Asymptomatic Seropositives (1989) (1)
Closing in on an infectious etiology of motor neuron disease (2016) (1)
Neurosyphilis in HIV-infected patients. (1993) (1)
HIV ENCEPHALOPATHY: CLINICAL AND DIAGNOSTIC CONSIDERATIONS (1995) (1)
Distribution andQuantity of Sites of John CunninghamVirus Persistence in Immunologically Healthy Patients (2017) (1)
JC virus: Progressive multifocal leukoencephalopathy (2003) (1)
Rapidly progressive dementia with hypoglycorrhachia (2015) (0)
Neurosyphilis in patients infected with human immunodeficiency virus (1990) (0)
Progressive Multifocal Leukoencephalopathy and Relapsing-Remitting Multiple Sclerosis (2016) (0)
Letter re: Burnout, career satisfaction, and well-being among US neurologists in 2016 (2017) (0)
A Case of PML after Initiation Of Brentuximab Vedotin For CD30 Positive Cutaneous T Cell Lymphoma (P7.032) (2014) (0)
Reassessing the risk of natalizumab-associated PML (2016) (0)
Neurosyphilis in Acquired Immunodeficiency Syndrome-Reply (1990) (0)
Short communication Intravascular lymphomatosis presenting with sudden hearing loss (2005) (0)
Editorial for JNV issue on PML (2015) (0)
JC Virus Reactivation with Natalizumab (2009) (0)
Case definitions for progressive multifocal leucoencephalopathy: a step in the right direction (2012) (0)
PML with dimethyl fumarate—No role for natalizumab? (2019) (0)
Progressive Multifocal Leukoencephalopathy [ version 1 ; peer review : 2 approved ] (2022) (0)
Podcast on B Cell-Targeting Therapies and Other Multiple Sclerosis Concerns During COVID-19 (2022) (0)
Chapter 45 – AIDS and the Nervous System (2008) (0)
Neuromuscular POLIOMYELITIS (2008) (0)
VIDEO Alien hand syndrome (2006) (0)
1H-MRS, MRI, and CSF predictors of HIV dementia Preliminary results from ongoing longitudinal studies (2002) (0)
Progressive multifocal leukoencephalopathy in the AIDS era (2011) (0)
Varicella zoster virus (VZV) oculomeningoencephalomyeloradiculitis: a previously undescribed constellation (2019) (0)
Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event (2018) (0)
CSF pleocytosis and syndrome of inappropriate antidiuretic hormone secretion in Creutzfeldt-Jakob disease. (2016) (0)
Correction to: Progressive multifocal leukoencephalopathy in rituximab-treated rheumatic diseases: a rare event (2018) (0)
Neurosyphilis in AIDS (2009) (0)
Neurological Complications of Antiviral Vaccines (2003) (0)
Substantia Nigra Depigmentation and Birth Cohorts: Remote Effect of Encephalitis Lethargica? (S42.006) (2012) (0)
Multiple sclerosis remission following antiretroviral therapy in an HIV-infected man (2014) (0)
Comprar HIV/AIDS and the Nervous System | Joseph Berger | 9780444520104 | Elsevier Science (2007) (0)
Physician Compensation in the United States - Through the Lens of the MS Neurologist. (2021) (0)
401 – Neurologic Complications of Human Immunodeficiency Virus Infection (2012) (0)
Reader Response: Acute Hypokinetic-Rigid Syndrome Following SARS-CoV-2 Infection (2021) (0)
Volitional opsoclonus (2005) (0)
Author response to Lalive et al. (2018) (0)
Intensive Care Evaluation of the Comatose Patient (1982) (0)
Progressive multifocal leukoencephalopathy after ﬁ ngolimod treatment (0)
Arthropod-borne virus encephalitis (2020) (0)
Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies (2017) (0)
Erratum to: Reassessing the risk of natalizumab-associated PML (2016) (0)
COVID-19 and the nervous system (2020) (0)
Cytomegalovirus (2020) (0)
199 Changes in natalizumab exposure and PML incidence over time (2019) (0)
HIV-Related Motor Neuron Disease (2001) (0)
Disease-modifying drugs for multiple sclerosis and JC virus expression (2012) (0)
Stroke in HIV infection (2009) (0)
A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy (2014) (0)
MATTERS ARISING Balint ' s syndrome in subacute HIV encephalitis (0)
Editorial for JNV issue on PML (2015) (0)
Learning More About HHV-6 Encephalitis (2021) (0)
Total Tau Level in Cerebrospinal Fluid as a Predictor of Survival in Creutzfeldt-Jakob Disease: A Retrospective Analysis. (2023) (0)
AIDS-associated upper motor neuron disease with unique radiographic findings (P2.307) (2017) (0)
378 – Cytomegalovirus, Epstein-Barr Virus, and Slow Virus Infections of the Central Nervous System (2012) (0)
Analysis of myopathy in a placebo-controlled zidovudine tiral (1996) (0)
Adenovirus (2020) (0)
Spinal cord progressive multifocal leukoencephalopathy detected premortem by MRI (2015) (0)
Summary of Meeting (1998) (0)
Use of Descriptive Terms in Medical Records-Reply. (2015) (0)
JCV in throat washings of normal and HIV-infected persons (2011) (0)
Clinical commentary for “Progressive multifocal leukoencephalopathy on dimethyl fumarate with preserved lymphocyte count but deep T-cells exhaustion” (2020) (0)
Faculty of 1000 evaluation for Progressive multifocal leukoencephalopathy: why gray and white matter. (2015) (0)
Association of Bilateral Internuclear Oph-thalmoplegia and Myelomeningocele with Arnold-Chiari Malformation , Type II . . . . 124 (2019) (0)
Cobalamine Deficiency (1997) (0)
Immunosenescence and the importance of age in risk stratification of progressive multifocal leukoencephalopathy (P2.318) (2017) (0)
A case of idiopathic recurrent inflammatory facial nerve paralysis (2022) (0)
Infectious Myelopathies (2011) (0)
Book Review HIV Neurology (Contemporary Neurology Series. Vol. 61.) By Bruce James Brew. 276 pp., illustrated. New York, Oxford University Press, 2001. $89.50. 0-19-513363-3 (2001) (0)
VIDEO Volitional opsoclonus (2005) (0)
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient (2015) (0)
Cerebellar seizures of Hughlings Jackson. (2000) (0)
Against all odds: surviving rhino–orbital–cerebral mucormycosis: a case report (2012) (0)
Presumptive human herpesvirus 6 myelopathy in an immunocompetent patient (2014) (0)
Case reports Wernicke's encephalopathy in the course of chemoradiotherapy for head and neck cancer (2011) (0)
Contrast enhancement in CT scanning (1980) (0)
The brain as an HIV-1 reservoir: Factors affecting HIV-1 infectivity (1993) (0)
Faculty Opinions recommendation of Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy. (2015) (0)
Commentary: Progressive multifocal leukoencephalopathy genetic risk variants for pharmacovigilance of immunosuppressant therapies (2023) (0)
GLOBAL PERSPECTIVES (2012) (0)
Clinical Infectious Disease: Progressive Multifocal Leukoencephalopathy (2008) (0)
Proceedings of the 10th International Conference on Neuroscience of HIV Infection: emerging issues. (2002) (0)

This paper list is powered by the following services:

Other Resources About Joseph Berger

en.wikipedia.org

What Schools Are Affiliated With Joseph Berger ?

Joseph Berger is affiliated with the following schools:

Joseph Berger 's Academic­Influence.com Rankings

Joseph Berger 's Degrees

Why Is Joseph Berger Influential?

Joseph Berger 's Published Works

Published Works

Other Resources About Joseph Berger

What Schools Are Affiliated With Joseph Berger ?

Joseph Berger 's AcademicInfluence.com Rankings